Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Dynamic Business Location.

University of Vienna: On the path to individual tumor therapies

structure of plecstatin-1 © University of Vienna

This identification has turned out to be quite difficult. For this reason, scientists assume that metal-based substances damage cancer cells in a rather unselective manner. In order to enable optimal therapeutic success, it is necessary to deploy customized drugs in an individualized approach with clear molecular targets and mechanisms of action. A research team led by Christopher Gerner from the Faculty of Chemistry of the University of Vienna has achieved a milestone in solving the well-known problem. In examining molecular target structures by means of mass spectrometry, especially metal-organic, ruthenium-containing substances, it became clear that it was not the DNA but proteins which are important target molecules.

"Our conclusions are cause for hope that target structures of other, already established drugs can now also be identified using well-known analytical processes and strategies”, says Christopher Gerner from the Faculty of Chemistry at the University of Vienna. In this way, important metal-organic substances can be integrated into the group of customized medicines which are available for individualized and thus personally optimized use. A substance, plecstatin, was discovered and characterized and can be deployed as a new type of customized drug for cancer therapy.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • ESIB 2019

    18. - 20.11.2019, Graz, Austria

  • Business Breakfast

    20.11.2019 / 8:45 - 11:00, London, UK

Austria Map

Find the perfect location for your company

Austria stands out due to its long-term reliable and stable conditions. These features are particularly important for a research-based company such as Boehringer Ingelheim. Furthermore, Vienna is a city with a good research infrastructure and a high quality of life, and is thus also an interesting place for highly qualified employees from Austria and abroad.

Boehringer Ingelheim

Logo
More testimonials

news from the business location Austria

Central European University launches EMBA for the Open World

With the opening of its Vienna campus, CEU is launching a thoroughly redesigned Executive MBA.

The Automobile Industry in Transition: Designed in Austria, Produced in China

Not a day goes by without reports being published on things happening in the automobile industry - positive as well as negative. The unfavourable stories usually focus on the issues of greenhouse gas emissions and the lack of environmental compatibility. The positive coverage mainly deals with activities and announcements about electric cars. The level of attention should not be surprising. The bottom line is that most of us use our own vehicles on a daily basis, and the global market is huge, consisting of 80 million new automobiles.

More news All blog posts